Susi Roger E. 4

What Happened
Roger E. Susi, a 10% owner of IRADIMED CORP (IRMD), sold a total of 7,500 shares in open-market transactions on March 16–17, 2026, for aggregate proceeds of approximately $762,971. The sales were: 3,009 shares at a weighted-average $101.18 ($304,451), 1,991 shares at $101.68 ($202,445), and 2,500 shares at $102.43 ($256,075). These were sales (not purchases), which are often routine liquidity events rather than a bullish signal.

Key Details

• Transaction dates: Mar 16, 2026 (two blocks) and Mar 17, 2026 (one block). All reported on Form 4 filed Mar 18, 2026 (timely).
• Prices reported: $101.18, $101.68, $102.43 (each is a weighted-average price; underlying trades were executed across the ranges noted in the footnotes).
• Total shares sold: 7,500; total proceeds: ~$762,971.
• Shares owned after transaction: Not disclosed in the provided filing details.
• Notable footnotes:
  • F1: Sales were made pursuant to a Rule 10b5‑1 trading plan adopted Nov 5, 2025.
  • F2–F4: Each reported price is a weighted average of multiple trades (ranges provided in the filing).
  • F5: The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.
• Filing timeliness: Reported within the typical two-business-day window (no late filing indicated).

Context
A 10b5‑1 plan lets insiders sell pre-scheduled amounts to avoid questions about trading on material nonpublic information; its presence means these sales were executed under a previously established plan. As these are sales by a 10% owner (a significant insider), they are notable for share movement and liquidity but do not, by themselves, indicate the insider’s view of the company’s prospects.